Scott Moore explores China’s trajectory in the worldwide biotechnology sector. Whilst The usa has become the dominant global participant in building and commercializing biotechnology for many years, China is decided to become a leading participant in biotechnology and is also investing seriously within the sector. Moore argues that, when the U.S.